Bull&Bear | GoHealth, Valhi, and CAVA Group Lead Bullish Surge While ZJYL and iQIYI Decline

Bullish Stocks:

GoHealth (GOCO) increased by 25.54%, marking a three-day consecutive rise and a 33.83% gain in the past three days. GoHealth is set to present and host a 1x1 investor meeting at the 15th Annual Midwest IDEAS Investor Conference in Chicago, Illinois on August 28.

Valhi (VHI) rose by 21.69%. Frequent shutdowns among industry giants have led to a sharp reduction in global production capacity of chemical materials, particularly MDI.

CAVA Group (CAVA) climbed by 19.63%. CAVA Group's Q2 earnings exceeded expectations, prompting multiple major financial institutions to raise their price targets for the company.

Fitell (FTEL) gained 19.20%. The company's stock rose alongside other large stocks such as Integral Ad Science, Willdan Group, and Del Monte Fresh Produce, following a positive earnings report from MercadoLibre.

Redfin (RDFN) went up by 18.88%, marking a two-day consecutive rise and a 22.57% gain over these two days. In July, home sales saw a slight increase while prices remained near historic highs.

Bearish Stocks:

ZJYL (ZJYL) fell by 12.54%. ZJYL released its 6-K foreign issuer report, showing performance below expectations.

iQIYI (IQ) declined by 10.00%, marking a two-day consecutive fall and a 24.03% drop over the past two days. iQIYI reported a total Q2 revenue of 7.4 billion yuan, a 5% year-over-year decrease.

Aihuishou International (RERE) dropped by 8.06%, marking a two-day consecutive fall and a 12.98% decline over these two days. ATRenew's Q2 2024 earnings call highlighted that the company's performance fell short of market expectations, with both revenue and net profit declining due to weak market demand and rising operating costs.

Gold Fields (GFI) decreased by 7.87%, marking a three-day consecutive fall and a 15.58% drop over these three days. The company is facing a decline in production but has maintained its dividend.

Soleno Therapeutics (SLNO) lost 6.89%, marking a two-day consecutive fall and a 12.76% decline over these two days. Soleno Therapeutics announced that Board Chairman Ernest Mario intends to resign from the board effective August 15, 2024.